Sunitinib therapy in renal cell carcinoma Journal Article


Authors: O'brien, M. F.; Russo, P.; Motzer, R. J.
Article Title: Sunitinib therapy in renal cell carcinoma
Keywords: cancer survival; treatment outcome; treatment response; clinical trial; fatigue; sorafenib; bevacizumab; sunitinib; diarrhea; drug dose reduction; drug efficacy; drug safety; nonhuman; side effect; antineoplastic agents; alpha interferon; cancer adjuvant therapy; cancer patient; combined modality therapy; cancer immunotherapy; multiple cycle treatment; nausea; stomatitis; kidney carcinoma; kidney neoplasms; nephrectomy; high risk patient; asthenia; dyspnea; fever; lymphocytopenia; carcinoma, renal cell; pancreatitis; pazopanib; short survey; skin discoloration; clear cell carcinoma; hypothyroidism; indoles; pyrroles; amylase blood level; hand foot syndrome; triacylglycerol lipase blood level; influenza; cytopenia; amylase; triacylglycerol lipase; progression-free survival; rcc; heart ejection fraction; platelet-derived growth factor inhibitor; vascular endothelial growth factor inhibitor
Journal Title: BJU International
Volume: 101
Issue: 11
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2008-06-01
Start Page: 1339
End Page: 1342
Language: English
DOI: 10.1111/j.1464-410X.2008.07506.x
PUBMED: 18284408
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 7" - "Export Date: 17 November 2011" - "CODEN: BJINF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Russo
    581 Russo
  2. Robert Motzer
    1243 Motzer
  3. Matthew Francis O'Brien
    20 O'Brien